Dehydroepiandrosterone inhibits the progression phase of mammary carcinogenesis by inducing cellular senescence via a p16-dependent but p53-independent mechanismReport as inadecuate




Dehydroepiandrosterone inhibits the progression phase of mammary carcinogenesis by inducing cellular senescence via a p16-dependent but p53-independent mechanism - Download this document for free, or read online. Document in PDF available to download.

Breast Cancer Research

, 7:R1132

First Online: 16 November 2005Received: 24 June 2005Revised: 10 October 2005Accepted: 12 October 2005

Abstract

IntroductionDehydroepiandrosterone DHEA, an adrenal 17-ketosteroid, is a precursor of testosterone and 17β-estradiol. Studies have shown that DHEA inhibits carcinogenesis in mammary gland and prostate as well as other organs, a process that is not hormone dependent. Little is known about the molecular mechanisms of DHEA-mediated inhibition of the neoplastic process. Here we examine whether DHEA and its analog DHEA 8354 can suppress the progression of hyperplastic and premalignant carcinoma in situ lesions in mammary gland toward malignant tumors and the cellular mechanisms involved.

MethodsRats were treated with N-nitroso-N-methylurea and allowed to develop mammary hyperplastic and premalignant lesions with a maximum frequency 6 weeks after carcinogen administration. The animals were then given DHEA or DHEA 8354 in the diet at 125 or 1,000 mg-kg diet for 6 weeks. The effect of these agents on induction of apoptosis, senescence, cell proliferation, tumor burden and various effectors of cellular signaling were determined.

ResultsBoth agents induced a dose-dependent decrease in tumor multiplicity and in tumor burden. In addition they induced a senescent phenotype in tumor cells, inhibited cell proliferation and increased the number of apoptotic cells. The DHEA-induced cellular effects were associated with increased expression of p16 and p21, but not p53 expression, implicating a p53-independent mechanism in their action.

ConclusionWe provide evidence that DHEA and DHEA 8354 can suppress mammary carcinogenesis by altering various cellular functions, inducing cellular senescence, in tumor cells with the potential involvement of p16 and p21 in mediating these effects.

AbbreviationsBrdUbromodeoxyuridine

DHEAdehydroepiandrosterone

ERestrogen receptor

ICHimmunocytochemical assay

MNUN-nitroso-N-methylurea

SA-β-Galsenescence-associated β-galactosidase.

Electronic supplementary materialThe online version of this article doi:10.1186-bcr1350 contains supplementary material, which is available to authorized users.

Download fulltext PDF



Author: Anne Shilkaitis - Albert Green - Vasu Punj - Vernon Steele - Ronald Lubet - Konstantin Christov

Source: https://link.springer.com/







Related documents